Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of BCD-066 vs Aranesp in Healthy Volunteers
NCT02506881Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of darbepoetin alfa in anemia (4 arms), sponsored by BIOCAD. Primary endpoints: Area Under the Curve, Maximum Concentration and 2 more. Started Mar 2013; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02506881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506881.